Barriers to preventive interventions for coronary heart disease (Q35585971)

9 August 2017

1 reference

title

Barriers to preventive interventions for coronary heart disease (English)

1 reference

9 August 2017

main subject

coronary artery disease

1 reference

Cardiology and cardiovascular medicine

inferred from title

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(03)00055-9

2 April 2024

2

Judith K Ockene

1 reference

9 August 2017

3

Ira S Ockene

1 reference

9 August 2017

David E. Chiriboga

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14621458

2 April 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14621458

2 April 2024

publication date

1 August 2003

1 reference

full work available at URL

9 August 2017

https://api.elsevier.com/content/article/PII:S0733865103000559?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(03)00055-9

https://api.elsevier.com/content/article/PII:S0733865103000559?httpAccept=text/plain

2 April 2024

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(03)00055-9

2 April 2024

1 reference

9 August 2017

volume

21

1 reference

9 August 2017

issue

3

1 reference

9 August 2017

page(s)

459-470

1 reference

The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence, mortality and cost

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Statin trials and goals of cholesterol-lowering therapy after AMI.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Compliance with National Cholesterol Education Program dietary and lifestyle guidelines among older women with self-reported hypercholesterolemia. The Women's Health Initiative

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Randomized clinical trials and recent patterns in the use of statins.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Methods used to quit smoking in the United States. Do cessation programs help?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Understanding risk in hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Dietary management of cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Coronary heart disease: dietary links and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Optimal diets for prevention of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Angioscopy and ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

United States Cholesterol Guidelines 2001: expanded scope of intensive low-density lipoprotein-lowering therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Quitting smoking: why, how, and what might help

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

The health benefits of smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Change in cholesterol awareness and action. Results from national physician and public surveys

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Clinical treatment of dyslipidemia: practice patterns and missed opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Specialty differences in cardiovascular disease prevention practices

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

From best evidence to best practice - what are the obstacles?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Stages and processes of self-change of smoking: toward an integrative model of change

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Benefits and costs of lifestyle change to reduce risk of chronic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Consistency between US dietary fat intake and serum total cholesterol concentrations: the National Health and Nutrition Examination Surveys

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

A case-management system for coronary risk factor modification after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

The best antiarrhythmic agent will be a lipid-lowering agent

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Promoting health and preventing disease in health care settings: an analysis of barriers

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Increasing the efficacy of physician-delivered smoking interventions: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Effect of physician-delivered nutrition counseling training and an office-support program on saturated fat intake, weight, and serum lipid measurements in a hyperlipidemic population: Worcester Area Trial for Counseling in Hyperlipidemia (WATCH).

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Health Education and the primary care physician: the practitioner's perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Toward a smoke-free society

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

The best anti-heart failure agent will be a lipid-lowering agent

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

A Survey of Massachusetts Physicians’ Smoking Intervention Practices

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Intensive lifestyle changes for reversal of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Early pharmacologic intervention and plaque stability in acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Plaque stabilization: a mechanism for the beneficial effect of lipid-lowering therapies in angiography studies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Guidelines accompanied by changes in reimbursement rules. Effects on lipid-lowering drug prescribing

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Getting cardiologists interested in lipids

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

A randomized trial to increase smoking intervention by physicians. Doctors Helping Smokers, Round I

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Physician training for patient-centered nutrition counseling in a lipid intervention trial

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Economic impact of community pharmacist intervention in cholesterol risk management: an evaluation of the study of cardiovascular risk intervention by pharmacists

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Primary care-based smoking interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Smoking cessation and severity of disease: the Coronary Artery Smoking Intervention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900055-9

7 January 2021

Review of cholesterol-lowering therapy: coronary angiographic and events trials

3

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(03)00055-9

Family physician recognition and treatment of severe hypercholesterolemia

2 April 2024

35

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(03)00055-9

The report to Congress on the appropriate federal role in assuring access by medical students, residents, and practicing physicians to adequate training in nutrition

2 April 2024

66

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(03)00055-9

A controlled trial to integrate smoking cessation advice into primary care practice: Doctors Helping Smokers, Round III

2 April 2024

70

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(03)00055-9

Health plans helping smokers

2 April 2024

71

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(03)00055-9

A controlled time-series trial of clinical reminders: using computerized firm systems to make quality improvement research a routine part of mainstream practice

2 April 2024

73

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(03)00055-9

How important are clinician and nurse attitudes to the delivery of clinical preventive services?

2 April 2024

76

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(03)00055-9

2 April 2024

Identifiers

1 reference

9 August 2017

1 reference